脓毒症相关急性呼吸窘迫综合征肺外风险预测列线图模型的开发与验证
该研究为回顾性分析,纳入新疆医科大学第一附属医院2023年4月至2025年3月收治的391例脓毒症患者(训练集273例、验证集118例),并从MIMIC-IV数据库提取400例作为外部验证集。按2012年柏林定义分为ARDS组与非ARDS组,采用LASSO及多因素Logistic回归筛选独立危险因素并构建列线图。结果显示SOFA心血管评分(OR=1.27)、凝血评分(OR=1.58)、神经评分(OR=1.34)、合并肺部感染(OR=2.63)及APACHE II评分(OR=1.40)为独立危险因素;模型在训练集、验证集、外部验证集的AUC分别为0.90、0.91、0.92,校准曲线和决策曲线显示良好校准度与临床实用性。
要点
- 在脓毒症患者中,SOFA心血管评分每升高1分,SA-ARDS风险增加27%(OR=1.27,95%CI 1.01-1.60,P=0.038)。
- SOFA凝血评分每升高1分,SA-ARDS风险增加58%(OR=1.58,95%CI 1.08-2.30,P=0.019)。
- SOFA神经评分每升高1分,SA-ARDS风险增加34%(OR=1.34,95%CI 1.10-1.63,P=0.003)。
- 合并肺部感染者SA-ARDS风险为无肺部感染者的2.63倍(OR=2.63,95%CI 1.25-5.52,P=0.011)。
- APACHE II评分每升高1分,SA-ARDS风险增加40%(OR=1.40,95%CI 1.28-1.53,P<0.001);列线图外部验证AUC=0.92(95%CI 0.89-0.94)。
适用人群与场景
- 新疆医科大学第一附属医院2023年4月至2025年3月收治的脓毒症患者391例(训练集273例、验证集118例),另从MIMIC-IV数据库提取脓毒症患者400例作为外部验证集。
诊断标准与关键阈值
- ARDS诊断依据2012年柏林定义,训练集273例中189例发生ARDS。
- 预测模型基于5个因素构建:SOFA心血管评分、SOFA凝血评分、SOFA神经评分、合并肺部感染、APACHE II评分。
- 模型在训练集AUC=0.90(95%CI 0.87-0.94),验证集AUC=0.91(95%CI 0.86-0.96),外部验证集AUC=0.92(95%CI 0.89-0.94)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的具体情况。
研究设计与关键结果
- 研究类型为回顾性分析,纳入院内脓毒症患者391例(训练集273例、验证集118例)及MIMIC-IV外部验证集400例,三组临床资料均衡可比(均P>0.05)。
- 多因素Logistic回归显示SOFA心血管评分(OR=1.27,95%CI 1.01-1.60,P=0.038)、SOFA凝血评分(OR=1.58,95%CI 1.08-2.30,P=0.019)、SOFA神经评分(OR=1.34,95%CI 1.10-1.63,P=0.003)、合并肺部感染(OR=2.63,95%CI 1.25-5.52,P=0.011)及APACHE II评分(OR=1.40,95%CI 1.28-1.53,P<
- 列线图模型在训练集、验证集、外部验证集的AUC分别为0.90(95%CI 0.87-0.94)、0.91(95%CI 0.86-0.96)、0.92(95%CI 0.89-0.94),校准曲线和决策曲线分析显示良好校准度与临床实用性。
证据类型、等级与局限
- 证据类型为回顾性队列研究(单中心院内数据+公共数据库外部验证),原文未提供证据等级或推荐强度。
- 局限:原文未明确列出;设计上为回顾性分析,院内数据来自单中心(新疆医科大学第一附属医院),外部验证为MIMIC-IV数据库回顾性数据,模型需前瞻性验证。
对床旁实践的改变
- 在脓毒症患者中,可关注SOFA心血管、凝血、神经子评分及APACHE II评分和是否合并肺部感染,用于SA-ARDS风险分层;该模型为预测工具,原文未提供临床决策阈值或干预方案,不能据此直接改变治疗。
- 适用人群为脓毒症患者(院内数据及MIMIC-IV数据库人群),原文未提及排除人群;常见陷阱是将预测模型的OR值或AUC误当作诊断阈值或治疗指征。
指南或共识出处
- 原文未提及指南或共识名称;研究数据来源为新疆医科大学第一附属医院及MIMIC-IV数据库。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the independent predictive value of extrapulmonary organ dysfunction for sepsis-associated acute respiratory distress syndrome (SA-ARDS) after controlling for baseline factors such as pulmonary infection, and to construct a corresponding nomogram prediction model and validate its predictive performance.
METHODS: A retrospective analysis was conducted on clinical data from patients with sepsis admitted to the First Affiliated Hospital of Xinjiang Medical University from April 2023 to March 2025. Patients were randomly divided into a training set and a validation set at a 7 : 3 ratio. Additionally, data from patients with sepsis were extracted from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database as an external validation set. The consistency of clinical data among the training set, validation set, and external validation set was compared. In the training set, patients were divided into ARDS group and non-ARDS group according to the 2012 Berlin definition of ARDS. Variables with significant differences in univariate analysis were incorporated into LASSO and Logistic regression models to identify independent risk factors for SA-ARDS, which were then used to construct a nomogram prediction model. The discriminative ability, calibration, and clinical utility of the model were evaluated using receiver operator characteristic curve (ROC curve), calibration curve, and decision curve analysis in the training set, validation set, and external validation set, respectively.
RESULTS: 391 sepsis patients were enrolled from the hospital, including 273 in the training set and 118 in the validation set. An additional 400 patients with sepsis were extracted from the MIMIC-IV database as the external validation set. The three groups were balanced and comparable in terms of clinical data (all P>0.05). Of the 273 patients in the training set, 189 developed ARDS. There were statistically significant differences in proportions of patients with pulmonary infection and septic shock, mean arterial pressure, serum lactate, platelet count, procalcitonin, total bilirubin, albumin, blood urea nitrogen, serum creatinine, brain natriuretic peptide, Glasgow Coma Score (GCS), extrapulmonary Sequential Organ Failure Assessment (SOFA) total score, SOFA total score, Acute Physiology and Chronic Health Evaluation II (APACHE II), and SOFA coagulation, hepatic, cardiovascular, renal, and neurological subscores between the ARDS and non-ARDS groups (all P<0.05). LASSO regression identified 13 potential predictors. Multivariate Logistic regression analysis revealed that elevated SOFA cardiovascular score [odds ratio (OR)=1.27, 95% confidence interval (95%CI) was 1.01-1.60, P=0.038], elevated SOFA coagulation score (OR=1.58, 95%CI was 1.08-2.30, P=0.019), elevated SOFA neurological score (OR=1.34, 95%CI was 1.10-1.63, P=0.003), concomitant pulmonary infection (OR=2.63, 95%CI was 1.25-5.52, P=0.011), and elevated APACHE II score (OR=1.40, 95%CI was 1.28-1.53, P<0.001) were independent risk factors for ARDS. A nomogram prediction model was constructed based on these five factors. ROC curve analysis demonstrated that the area under the curve (AUC) of the prediction model in the training set, validation set, and external validation set was 0.90 (95%CI was 0.87-0.94), 0.91 (95%CI was 0.86-0.96), and 0.92 (95%CI was 0.89-0.94), respectively. Calibration curve and decision curve analysis indicated that the model exhibited good calibration and clinical utility.
CONCLUSIONS: After comprehensively adjusting for confounding factors including pulmonary infection and the severity of systemic disease, the SOFA cardiovascular, coagulation, and neurological subscores were identified as independent extrapulmonary influencing factors for SA-ARDS. The nomogram model incorporating these factors along with pulmonary infection and APACHE II score demonstrates favorable predictive performance and promising clinical application prospects, offering new insights for the clinical diagnosis and management of SA-ARDS.
参考来源
- Subinuer S, Wang K, Sun H, et al. [Development and validation of a nomogram model for extrapulmonary risk prediction in sepsis-associated acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42693966. doi:10.3760/cma.j.cn121430-20260313-00119
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。